About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Aurobindo Pharma Receives FDA Approval to Manufacture Generic Narcolepsy Drug

Aurobindo Pharma Receives FDA Approval to Market Generic Narcolepsy Drug

by Kathy Jones on Sep 29 2012 2:38 PM

Aurobindo Pharma Receives FDA Approval to Manufacture Generic Narcolepsy Drug

Indian drug maker Aurobindo Pharma revealed that it has received approval from the US Food and Drug Administration to manufacture modafinil tablets in the US.

The company said that it has received approval to manufacture the tablets in 100 mg and 200 mg strengths and added that the tablets were approved out of its Unit-VII formulations facility in Hyderabad.

Narcolepsy - Overview Incidence Causes Symptoms Diagnosis Treatment Prognosis Prevention FAQs

Narcolepsy - Overview Incidence Causes Symptoms Diagnosis Treatment Prognosis Prevention FAQs
Sleep is the blissful state that rejuvenates our mind and body everyday and any deprivation often leads to a disorder that can affect our health

Modafinil tablets are generic versions of Provigil tablets manufactured by Cephalon Inc and are used in treating narcolepsy, shift work sleep disorders and excessive daytime sleepiness associated with obstructive sleep apnea. According to figures from IMS Health, modafinil tablets accounted for more than $1.2 billion in sales for the last 12 months ending March 2012.

Source-Medindia

About Hypersomnia

About Hypersomnia
Hyper means “excessive” and somnia refers to “sleep”, so hypersomnia is excessively long or deep sleep despite sleeping for several hours at night.

Obstructive Sleep Apnea - Overview

Obstructive Sleep Apnea - Overview
Obstructive sleep apnea should be suspected in overweight middle aged adults who snore loudly and which can cause interruption of breathing for 10 seconds or more and this results in reduced blood o

Recommended Readings

Sleep Disorders: A Prelude

Sleep Disorders: A Prelude

Sleep disorders include difficulty falling/staying asleep, falling asleep at inappropriate times, excessive sleep or abnormal behaviors associated with sleep.

REM Behavior Disorder

REM Behavior Disorder

REM Behavior Disorder (RBD) is a sleep disorder in which the person acts out dramatic or violent dreams during Rapid Eye Movement (REM) sleep.

Sleep Paralysis

Sleep Paralysis

Sleep paralysis is a temporary inability to move or speak or react. This occurs when the patient is trying to wake up or fall asleep.

Narcolepsy

Sleep is the blissful state that rejuvenates our mind and body everyday and any deprivation often leads to a disorder that can affect our health

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Parasomnias - Part II

Parasomnias - Part II

Educating the patient, the bed partner or care taker is important for the management of Parasomnias

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement